methylprednisolone has been researched along with Hepatolenticular Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruguera-Àvila, N; Garcia-Olivé, I; Martínez-Barenys, C; Pérez-Ochoa, JF; Ruiz-Manzano, J; Sánchez-Martínez, E | 1 |
| Gong, G; Tian, Y; Yang, X | 1 |
| Bienaimé, F; Clerbaux, G; Mougenot, B; Plaisier, E; Ronco, P; Rougier, JP | 1 |
3 other study(ies) available for methylprednisolone and Hepatolenticular Degeneration
| Article | Year |
|---|---|
Obliterating bronchiolitis in a patient treated with (D)-penicillamine.
Topics: Bronchiolitis Obliterans; Bronchodilator Agents; Chelating Agents; Chelation Therapy; Combined Modality Therapy; Copper; Dyslipidemias; Graves Disease; Hepatolenticular Degeneration; Humans; Hypertension; Lung Transplantation; Male; Methylprednisolone; Middle Aged; Oxygen Inhalation Therapy; Penicillamine; Respiratory Insufficiency; Tomography, X-Ray Computed | 2013 |
[Prognosis and treatment of fulminant Wilson's disease].
Topics: Chelating Agents; Combined Modality Therapy; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Methylprednisolone; Plasma Exchange; Prognosis; Retrospective Studies; Unithiol | 2011 |
D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Chelating Agents; Creatinine; Disease Progression; Female; Glomerulonephritis; Glucocorticoids; Hepatolenticular Degeneration; Humans; Kidney Function Tests; Kidney Glomerulus; Methylprednisolone; Necrosis; Penicillamine; Peroxidase; Vasculitis | 2007 |